Table III.
Differences in Clinical and Biochemical Characteristics Among Patients With and Without the Metabolic Syndrome (MS) (Final‐Baseline)
| Patients With MS | Patients Without MS | P Value | |
|---|---|---|---|
| No. | 231 | 318 | |
| Weight, kg | 0.41±6.18 | 1.37±5.47 | .056 |
| BMI, kg/m2 | 0.16±2.28 | 0.47±2.07 | .100 |
| SBP, mm Hg | −14.64±28.86 | −12.56±24.86 | .374 |
| DBP, mm Hg | −10.92±12.18 | −8.49±11.47 | .019 |
| Antihypertensive drugs, No. | 0.34±0.82 | 0.37±0.771 | .936 |
| BP control, % | 31.4 | 31.4 | .999 |
| Glycemia, mg/dL | −1.88±16.68 | −0.13±19.67 | .272 |
| Total cholesterol, mg/dL | −10.66±36.00 | −3.07±36.7 | .016 |
| LDL cholesterol, mg/dL | −12.53±34.93 | −6.40±32.03 | .035 |
| HDL cholesterol, mg/dL | 4.27±13.50 | 1.39±10.39 | .005 |
| Triglycerides, mg/dL | −4.90±55.35 | 7.66±44.72 | .003 |
| Serum creatinine, mg/dL | −0.02±0.28 | −0.01±0.19 | .945 |
| Estimated GFR, mL/min/1.73 m2 | 1.37±23.68 | 0.86±20.71 | .811 |
| Microalbuminuria, mg/24 h | −9.91±47.74 | −9.66±48.77 | .960 |
| Microalbuminuria, % | −20.6 | −18.7 | .516 |
| Smokers, % | −2.0 | −2.1 | .890 |
| Abbreviations: BMI, body mass index; BP, blood pressure; DBP, diastolic blood pressure; GFR, glomerular filtration rate; HDL, high‐density lipoprotein; LDL, low‐density lipoprotein; SBP, systolic blood pressure. | |||